For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
COVID numbers: Bringing out the unnamed dead
Wednesday 19 August 2020, 02:45 AM

In the past few months of COVID-19, we have heard little about the dead themselves
JUST WONDERING
As the coronavirus numbers rise inexorably, Lucy O’Hagan ponders the anonymity of many of those whom the disease has claimed
I caught myself recently looking at a number, something like 858. It was the number of people who had died in one day, somewhere in the world, and I t
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.